🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "focused measures to tackle household expense issues" in next month's Budget.

During an interview with media outlets, she emphasized that lowering price rises is a joint duty of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the G7 advanced economies this year and the following year.

Potential Energy Bill Measures

Sources suggest the administration could intervene to bring down utility costs, for example by slashing the current 5% level of VAT applied on energy supplies.

An additional approach is to cut some of the regulatory levies presently included in household expenses.

Fiscal Limitations and Expert Predictions

The administration will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for such measures.

The consensus from most analysts is that the Chancellor will have to declare higher taxes or expenditure reductions in order to adhere to her voluntary fiscal targets.

Earlier on the same day, calculations suggested there was a £22 billion gap for the Treasury chief to address, which is at the more modest range of expectations.

"There's a shared responsibility between the central bank and the government to bear down further on some of the drivers of price increases," Reeves informed reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and Global Concerns

While much of the attention has been on likely tax increases, the chancellor said the most recent figures from the fiscal watchdog had not altered her pledge to manifesto promises not to increase tax levels on income tax, VAT or National Insurance.

She blamed an "uncertain world" with rising geopolitical and trade tensions for the fiscal tax moves, likely to be targeted on those "most able to pay."

Global Economic Disputes

Referring to worries about the United Kingdom's commercial links with China she said: "Our security interests invariably come first."

Recent declaration by China to tighten export controls on rare earths and other materials that are crucial for high-technology manufacturing led US President Donald Trump to threaten an extra 100% import tax on goods from China, raising the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary called China's decision "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the move was "bad for the global economy and generates further obstacles."

"I believe there are sectors where we need to challenge China, but there are also important prospects to export to China's economy, including financial services and other sectors of the economy. We've got to achieve that balance right."

The chancellor also stated she was collaborating with international partners "regarding our own critical minerals strategy, so that we are reduced dependence."

NHS Medicine Pricing and Funding

Reeves also admitted that the cost the National Health Service pays for pharmaceuticals could increase as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling projects in the United Kingdom, with several blaming the modest returns they are getting.

Last month, the government science advisor said the cost the health service spends on drugs would must rise to prevent businesses and pharmaceutical investment leaving the United Kingdom.

Reeves told the BBC: "We have seen because of the payment system, that clinical trials, new drugs have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to guarantee that patients receiving care from the NHS are able to access the top life-saving treatments in the world. And so we are examining this situation, and... looking to obtain additional funding into the UK."